Therapeutic Area Lead, Lymphoid & Myeloid Malignancies, Medical Affairs Oncology

Johnson & Johnson Innovative Medicine•Horsham, PA

2d•Hybrid

About The Position

Johnson & Johnson Innovative Medicine is recruiting a Therapeutic Area Lead for Lymphoid and Myeloid Malignancies within Medical Affairs Oncology. This office-based role is based preferably in Horsham, Pennsylvania, with onsite work at least three days per week. The role supports multiple products in the lymphoid and myeloid malignancy space, along with pipeline and emerging products, and reports directly to the VP, Medical Affairs, Oncology & Hematology. The role is part of the Medical Affairs Leadership Team and leads Medical Directors responsible for therapeutic-area medical strategy. The Therapeutic Area Lead develops medical strategies addressing scientific and medical needs and supporting appropriate use of Johnson & Johnson Medical Affairs products. The role partners across Medical Affairs, Global Medical Affairs, R&D, RW V&E (HECOR), Commercial, and other functions, as well as relevant alliance partners. It also provides medical oversight for Medical Affairs-led trials; oversees investigator-initiated study strategy and conduct, advisory board strategy, compliant promotional materials and representative training; supports scholarly publications, product monographs, and product inquiry responses; and escalates funding needs to the Medical Affairs VP and US Franchise President. The role concurrently serves as MSL Head for Lymphoid and Myeloid Malignancies, including pipeline and emerging products. It sets Field Medical strategy and priorities, leads two Field Directors, aligns field execution and resources with therapeutic-area and Medical Affairs objectives, and ensures field insights inform strategy, evidence generation, communications, and pipeline planning. It also develops Field Directors, connects headquarters and Field Medical teams, and evaluates Field Medical effectiveness.

Requirements

Experience and knowledge in treatment of lymphoid and myeloid malignancies, drug development, and Medical Affairs.
Strong insight into the lymphoid and myeloid malignancy therapeutic area and knowledge of the US market.
At least 10 years of experience, including subspecialty training, and at least 5 years of pharmaceutical industry experience.
A strong track record developing and implementing clinical research and medical strategies, including evaluation of value-oriented research and communication strategies.
People management experience.
Ability to travel up to 30% domestically and/or internationally.

Nice To Haves

MD, preferably as a Medical Oncologist and/or Hematologist.

Responsibilities

Serve as a member of the Medical Affairs Leadership Team and lead Medical Directors responsible for lymphoid and myeloid malignancy products, pipeline, and emerging assets.
Develop overall medical strategies to address medical and scientific issues and ensure appropriate use of relevant Johnson & Johnson Medical Affairs-supported products.
Provide strategic Medical Affairs leadership for pipeline and emerging products, partnering cross-functionally to assess evolving scientific and medical needs and support portfolio evolution and future asset readiness.
Identify and address strategic gaps through relationships across Medical Affairs, Global Medical Affairs, R&D, RW V&E (HECOR), Commercial, and other functions; lead partnerships with relevant alliance companies.
Elevate funding needs to the Medical Affairs VP and US Franchise President.
Provide medical monitoring and oversight for company-sponsored Medical Affairs-led interventional and observational clinical trials.
Oversee development and implementation of Investigator Initiated Study strategy and assess and supervise study conduct with support from direct reports.
Oversee medical support for development of compliant promotional materials and product representative training, and support Commercial functions.
Oversee development and implementation of Advisory Board strategy and maintain relationships with external investigators and opinion leaders.
Ensure scholarly publications from Medical Affairs studies are developed and work with Scientific Communications on broader communication strategy.
Support development of product monographs and responses to product inquiries.
Serve concurrently as MSL Head for Lymphoid and Myeloid Malignancies, establishing Field Medical strategy and aligning it with therapeutic-area and Medical Affairs strategy.
Lead two Field Directors responsible for executing Field Medical strategy across the Lymphoid and Myeloid Malignancies MSL organization.
Set strategic direction and priorities for Field Medical, translating therapeutic-area objectives, evidence needs, pipeline priorities, and evolving scientific needs into actionable field strategy.
Partner with Field Directors to ensure consistent strategy execution, appropriate MSL activity prioritization, and alignment of field resources with high-priority scientific and medical needs.
Set MSL engagement priorities, including scientific exchange, external stakeholder engagement, insight generation, and identification of emerging medical and scientific needs.
Ensure field insights are synthesized and incorporated into therapeutic-area strategy, evidence generation priorities, scientific communications, and pipeline planning.
Connect headquarters and Field Medical teams so strategic priorities are translated into field execution and field perspectives inform Medical Affairs decisions.
Provide leadership, coaching, and development to Field Directors and foster a high-performing Field Medical organization.
Partner across Medical Affairs and other functions to evolve Field Medical strategy in line with the scientific landscape, portfolio priorities, and healthcare professional and patient needs.
Establish measures of Field Medical effectiveness and use insights and performance indicators to refine strategy and execution.